MedTrace Logo

Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C

NCT05035693 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2024-11-15

No results posted yet for this study

Summary

Study design: International, prospective, multicentre, non-randomised, observational study according to § 23b MPG.

Objectives: Observational study to confirm the safety and performance of the cervical disc prosthesis MOVE®-C.

Conditions

  • Discopathy
  • Herniated Cervical Disc
  • Stenoses, Spinal
  • Radiculopathy

Interventions

DEVICE

MOVE®-C

Momo- or bisegmental implantation of MOVE®-C cervical prothesis.

Sponsors & Collaborators

  • NGMedical GmbH

    lead INDUSTRY

Principal Investigators

  • Olaf Süss, PD Dr. med. · DRK Kliniken Berlin

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-11
Primary Completion
2025-03-11
Completion
2027-03-11

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05035693 on ClinicalTrials.gov